sameAs
Imputation and subset based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33Analysis of heritability and shared heritability based on genome-wide association studies for thirteen cancer typesPhysical activity and all-cause mortality across levels of overall and abdominal adiposity in European men and women: the European Prospective Investigation into Cancer and Nutrition Study (EPIC)Prognostic and predictive markers in pancreatic adenocarcinomaNew Advances in the Treatment of Metastatic Pancreatic CancerTGF-β1-induced EMT promotes targeted migration of breast cancer cells through the lymphatic system by the activation of CCR7/CCL21-mediated chemotaxisDistinct expression of type XIII collagen in neuronal structures and other tissues during mouse developmentThree new pancreatic cancer susceptibility signals identified on chromosomes 1q32.1, 5p15.33 and 8q24.21A mutant collagen XIII alters intestinal expression of immune response genes and predisposes transgenic mice to develop B-cell lymphomas.Plasma Micro-RNA Alterations Appear Late in Pancreatic Cancer.Type IV collagen stimulates pancreatic cancer cell proliferation, migration, and inhibits apoptosis through an autocrine loopGenes-environment interactions in obesity- and diabetes-associated pancreatic cancer: a GWAS data analysis.The association of coffee intake with liver cancer risk is mediated by biomarkers of inflammation and hepatocellular injury: data from the European Prospective Investigation into Cancer and Nutrition.Function of endogenous inhibitors of angiogenesis as endothelium-specific tumor suppressorsComplete exon-intron organization and chromosomal location of the gene for mouse type XIII collagen (col13a1) and comparison with its human homologue.Dietary flavonoid and lignan intake and breast cancer risk according to menopause and hormone receptor status in the European Prospective Investigation into Cancer and Nutrition (EPIC) Study.Family history of cancer and risk of pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan).Post-GWAS gene-environment interplay in breast cancer: results from the Breast and Prostate Cancer Cohort Consortium and a meta-analysis on 79,000 womenGenome-wide association study identifies multiple susceptibility loci for pancreatic cancer.Identification of the NC1 domain of {alpha}3 chain as critical for {alpha}3{alpha}4{alpha}5 type IV collagen network assembly.Additive interactions between susceptibility single-nucleotide polymorphisms identified in genome-wide association studies and breast cancer risk factors in the Breast and Prostate Cancer Cohort Consortium.Inflammatory and metabolic biomarkers and risk of liver and biliary tract cancer.Bone-marrow-derived stem cells repair basement membrane collagen defects and reverse genetic kidney disease.Reproductive factors and risk of hormone receptor positive and negative breast cancer: a cohort studyA genome-wide "pleiotropy scan" does not identify new susceptibility loci for estrogen receptor negative breast cancer.Vitamin D-associated genetic variation and risk of breast cancer in the breast and prostate cancer cohort consortium (BPC3).Circulating prolactin and in situ breast cancer risk in the European EPIC cohort: a case-control study.Tumor stroma derived biomarkers in cancer.Genetic risk variants associated with in situ breast cancer.Genetic Polymorphisms in Vitamin D Metabolism and Signaling Genes and Risk of Breast Cancer: A Nested Case-Control StudyConcentrations of IGF-I and IGFBP-3 and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition.Zebrafish to humans: evolution of the alpha3-chain of type IV collagen and emergence of the autoimmune epitopes associated with Goodpasture syndrome.The contribution of vascular basement membranes and extracellular matrix to the mechanics of tumor angiogenesis.Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancerInflammation marker and risk of pancreatic cancer: a nested case-control study within the EPIC cohort.Modifiable causes of premature death in middle-age in Western Europe: results from the EPIC cohort study.Association of breast cancer risk loci with breast cancer survival.Adiposity, hormone replacement therapy use and breast cancer risk by age and hormone receptor status: a large prospective cohort studyEndogenous stimulators and inhibitors of angiogenesis in gastrointestinal cancers: basic science to clinical application.Improved tumour marker sensitivity in detecting colorectal liver metastases by combined type IV collagen and CEA measurement.
P50
Q23924183-41A0EF17-1AD4-4A6A-8EF1-F2CCB099C44EQ24170413-1ECB3140-F752-47BE-AD75-BFFF8BC2B1AAQ26256419-DA805AE7-89F8-497E-9FD8-FB57F5A28AEBQ26771965-E3019E83-9CC2-4F39-903C-40FC0B9F9045Q26786854-DD61C35E-8947-467A-8C62-CC7818A2C279Q27310034-9F1A662C-0E77-4698-9E3F-78C9B22CED13Q28589861-E446CE61-2C4E-407B-96D8-4B3817AAF05AQ29248193-EB2242D5-A5EE-4F2D-B2B7-E34FB03EECFBQ30490198-2E553C76-B518-4B1E-A281-709FFEF85C9FQ30491447-C9826CEB-C690-4B74-954C-FFDFAE605FD9Q30538449-543E5A78-CEFB-4048-944E-C9DA90953248Q30679678-6B9AC7BC-581B-4C1C-AB05-2AADF6281E33Q31022208-492DCF69-A435-479E-A107-9DFD92A51096Q33864448-2E4A23DB-7597-49DA-9B10-0088E5ADBE53Q33869695-A26EA958-FC61-4F65-989F-AA3B394A0F81Q34036279-FCB2B9A1-59F9-412B-A319-908B455A52B6Q34080597-C02DA19E-EC27-43F0-80E1-B117E87E57E9Q34155371-37A9A6DE-9ADE-4469-B14F-78B98441D514Q34314018-1A149FD3-BB51-4C1F-A03D-0DE215B52D19Q34439002-16A27554-1787-4AF6-A68B-93F4FB0EFA1FQ34472668-676FA5D5-02CB-4203-B7C1-6E9377BBDE07Q34511085-749AC6FC-DAD5-4CD4-82AF-1E2C420A77C8Q34624477-8D64589A-644A-46C0-A277-DE55B76475DDQ35062955-9C2F3DD3-2117-418A-838E-BF4334A006F0Q35093501-556A3F1E-9E78-45B3-A8F1-DDBB7E5032C7Q35164176-892FF628-D551-4576-94E9-99B90C69C95DQ35549885-7B002B35-7DE3-4809-8368-A14C316C92FFQ35765454-93E03B1D-0C23-4825-B875-01FF59366000Q35806601-8E29E0F4-D203-40B5-B21F-930FC62C6854Q35815989-4056B6D8-D4E4-4FF4-8087-910BF0FB7306Q35835118-1954127E-C2B0-47A0-8076-817E68FE7B7EQ35849436-E85A2479-2098-410B-84B9-FC08F46C3B5EQ35962617-1DF581E8-6332-489C-AD44-E68771918B05Q35996692-EB61A1BC-2EDC-4024-8716-C19CFE280C34Q35998414-3885C3FB-5206-419F-8F61-5A731B180D35Q36051022-71FE1A18-58FC-4FFE-A5D7-16D689A25E9CQ36191018-E165002D-002C-408F-8990-9A1AECA4F22EQ36245367-F9CF2CC3-0620-4E30-B01E-9A16562CFB62Q36339231-CA814988-B918-42F2-9F79-EDB60D9A1FFAQ36400239-D6411C63-F623-40CB-8B9C-2F78F51361BD
P50
description
Zweeds onderzoekster
@nl
hulumtuese
@sq
researcher
@en
svensk forsker
@nb
taighdeoir
@ga
հետազոտող
@hy
name
Malin Sund
@ast
Malin Sund
@da
Malin Sund
@de
Malin Sund
@en
Malin Sund
@es
Malin Sund
@fr
Malin Sund
@ga
Malin Sund
@nb
Malin Sund
@nl
Malin Sund
@nn
type
label
Malin Sund
@ast
Malin Sund
@da
Malin Sund
@de
Malin Sund
@en
Malin Sund
@es
Malin Sund
@fr
Malin Sund
@ga
Malin Sund
@nb
Malin Sund
@nl
Malin Sund
@nn
prefLabel
Malin Sund
@ast
Malin Sund
@da
Malin Sund
@de
Malin Sund
@en
Malin Sund
@es
Malin Sund
@fr
Malin Sund
@ga
Malin Sund
@nb
Malin Sund
@nl
Malin Sund
@nn
P108
P1153
9844178800
P19
P21
P27
P31
P496
0000-0002-7516-9543
P569
1972-06-06T00:00:00Z